Treatment algorithm

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer

ACUTE

all patients

Back
1st line – 

corticosteroid

Evidence supports the use of oral corticosteroids within 72 hours of symptom onset in all patients with Bell's palsy to shorten the time to complete recovery and to improve long-term outcomes, regardless of the baseline severity of facial palsy.[42]​​[43]​​[44][45][47][48][49][50][51] [ Cochrane Clinical Answers logo ] [Evidence A]

Caution should be exercised for the use of high-dose corticosteroids in children (aged <16 years) and in patients with poorly controlled diabetes mellitus, immunodeficiency, poorly controlled hypertension, and prior history of psychosis.

Make sure to exclude Lyme disease-associated facial paralysis when working up Bell’s palsy, as steroids may worsen long-term outcomes in these patients.[53]​​

The two main trials on which the recommendation is made involved adults. One study used 25 mg twice daily for 10 days and the other used 60 mg once daily for 5 days followed by a tapering dose.[45][48]​​​ Evidence from subgroup analysis has demonstrated improved outcomes for prednisolone-equivalent doses totalling 450 mg or higher.[55] One systematic review and meta-analysis comparing standard-dose corticosteroids with higher-dose corticosteroids found that higher-dose corticosteroids reduced incomplete recovery in patients with Bell’s palsy but did not identify a suitable dose.[52]​​

Primary options

prednisolone: 60 mg orally once daily for 5 days, then 50 mg once daily for 1 day, then 40 mg once daily for 1 day, then 30 mg once daily for 1 day, then 20 mg once daily for 1 day, then 10 mg once daily for 1 day, then stop

Back
Plus – 

eye protection

Treatment recommended for ALL patients in selected patient group

Keratoconjunctivitis sicca (dry eye) is common and may lead to exposure keratopathy. During the daytime, glasses may be worn and artificial tears may be used as needed. Overnight, ophthalmic lubricant should be applied, and the eyelid should be taped closed. Eye patching should be avoided as the eye may easily open under the patch leading to corneal abrasion.

Indications for ophthalmological consultation include: only seeing eye affected, suspicion of exposure keratopathy, and decreased or absent corneal sensation.

Strong consideration for early upper eyelid weight placement or tarsorrhaphy (both of which are reversible) should be given to patients who lack Bell’s phenomenon (protective reflex in which the globe rotates upwards and outwards with attempts at eye closure) or whose prognosis for early rapid return of function is poor (complete flaccid paralysis on presentation, older adult, taste disturbance, and diabetes mellitus).[37]

Back
Consider – 

concurrent antiviral therapy

Additional treatment recommended for SOME patients in selected patient group

Meta-analyses have found moderate-quality evidence that the combination of an antiviral and a corticosteroid reduces long-term sequelae of Bell's palsy compared with a corticosteroid alone, especially in patients who initially present with complete or near-complete facial palsy.[47][54]​​[55][56][57]​ No increase in adverse events from the addition of antiviral therapy to a corticosteroid regimen has been demonstrated, although the evidence is uncertain because of the lack of high-quality studies.[47] [ Cochrane Clinical Answers logo ]

Valaciclovir is a prodrug of aciclovir that has demonstrated improved pharmacokinetics and improved time to resolution of acute herpes zoster neuritis over aciclovir.[68] Additionally, its twice-daily dosing schedule promotes higher compliance than the five times-daily dosing required for aciclovir. As such, when antivirals are prescribed, it is the preferred option. 

Primary options

valaciclovir: 500-1000 mg orally twice or three times daily for 5-7 days

Secondary options

aciclovir: 400 mg orally five times daily for 10 days

Back
Consider – 

surgical decompression

Additional treatment recommended for SOME patients in selected patient group

Refer patients presenting with Bell palsy and meeting all of the following criteria to a neuro-otoloigst to discuss the risks and benefits of surgical decompression:

Clinically undetectable unilateral facial movement

Facial palsy onset within 14 days

Electroneuronography (ENoG) performed between 72 hours and 14 days of facial palsy onset demonstrates >90% reduction in the amplitude of the compound muscle action potential (CMAP) using a suprathershold neural stimulus compared with the normal side.

Needle electromyography (EMG) confirms the absence of voluntary motor unit potentials in the facial musculature.

back arrow

Choose a patient group to see our recommendations

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer

Use of this content is subject to our disclaimer